国际外科学杂志
國際外科學雜誌
국제외과학잡지
INTERNATIONAL JOURNAL OF SURGERY
2013年
1期
46-49
,共4页
亚肺叶切除术%肺切除术%癌%非小细胞肺
亞肺葉切除術%肺切除術%癌%非小細胞肺
아폐협절제술%폐절제술%암%비소세포폐
Sublobar resection%Pneumonectomy%Carcinoma%non-small-cell lung
临床Ⅰ期或Ⅱ期非小细胞肺癌患者有可能通过手术达到治愈,肺外科手术的方式有肺叶切除术及亚肺叶切除术.目前肺叶切除术是治疗早期非小细胞肺癌的标准术式,但越来越多的研究涉及亚肺叶切除治疗早期非小细胞肺癌,争议也一直存在,对于提高亚肺叶切除的疗效的研究也层出不穷.本文就亚肺叶切除治疗早期非小细胞癌的疗效以及影响其疗效的因素作一综述.
臨床Ⅰ期或Ⅱ期非小細胞肺癌患者有可能通過手術達到治愈,肺外科手術的方式有肺葉切除術及亞肺葉切除術.目前肺葉切除術是治療早期非小細胞肺癌的標準術式,但越來越多的研究涉及亞肺葉切除治療早期非小細胞肺癌,爭議也一直存在,對于提高亞肺葉切除的療效的研究也層齣不窮.本文就亞肺葉切除治療早期非小細胞癌的療效以及影響其療效的因素作一綜述.
림상Ⅰ기혹Ⅱ기비소세포폐암환자유가능통과수술체도치유,폐외과수술적방식유폐협절제술급아폐협절제술.목전폐협절제술시치료조기비소세포폐암적표준술식,단월래월다적연구섭급아폐협절제치료조기비소세포폐암,쟁의야일직존재,대우제고아폐협절제적료효적연구야층출불궁.본문취아폐협절제치료조기비소세포암적료효이급영향기료효적인소작일종술.
The curative treatment of choice for stage Ⅰ or Ⅱ non-small cell lung cancer (NSCLC) patients is usually surgical resection and the two surgical resection methods are lobectomy and sublobar resection.At present,the standard resection for early stage NSCLC is lobectomy.But more and more researches involve the sublobar resection for early stage NSCLC and its effect has been controversial.The research of how to improve the outcomes of sublobar resection is also emerging endlessly.The present paper reviews the effect of sublobar resection and the factors of impacting on its curative effect.
